Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 6,007,000 | 6,273,000 | 5,920,000 | 5,973,000 | 5,691,000 |
| Cost of Goods | 1,790,000 | 1,972,000 | 1,824,000 | 1,610,000 | 1,648,000 |
| Gross Profit | 4,217,000 | 4,301,000 | 4,096,000 | 4,363,000 | 4,043,000 |
| Operating Expenses | 2,868,000 | 2,525,000 | 2,117,000 | 2,858,000 | 1,876,000 |
| Operating Income | 1,349,000 | 1,776,000 | 1,979,000 | 1,505,000 | 2,167,000 |
| Pre-tax Income | 1,349,000 | 1,776,000 | 1,979,000 | 1,505,000 | 2,167,000 |
| Income Tax | -17,000 | 337,000 | 264,000 | 347,000 | 255,000 |
| Net Income Continuous | 1,366,000 | 1,439,000 | 1,715,000 | 1,158,000 | 1,912,000 |
| Minority Interests | 13,000 | 7,000 | 5,000 | -2,000 | 11,000 |
| Net Income | $1,353,000 | $1,432,000 | $1,710,000 | $1,160,000 | $1,901,000 |
| EPS Basic Total Ops | 0.83 | 0.88 | 1.05 | 0.71 | 1.16 |
| EPS Basic Continuous Ops | 0.84 | 0.88 | 1.05 | 0.71 | 1.17 |
| EPS Diluted Total Ops | 0.83 | 0.87 | 1.04 | 0.71 | 1.16 |
| EPS Diluted Continuous Ops | 0.84 | 0.88 | 1.05 | 0.71 | 1.17 |
| EBITDA(a) | $1,520,000 | $1,945,000 | $2,149,000 | $1,677,000 | $2,332,000 |